Form 4: Fulgent Genetics CFO Paul Kim Sells Shares to Cover Tax Obligations

Fulgent Genetics CFO and Treasurer, Paul Kim, sold 1,553 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Paul Kim, the CFO and Treasurer of Fulgent Genetics, Inc., sold 1,553 shares of common stock on December 1, 2024.
• The sale was executed at a price of $18.3 per share.
• This transaction was to satisfy tax withholding obligations arising from the vesting of restricted stock units granted on February 28, 2022.
• Following the transaction, Mr. Kim directly owns 204,521 shares of Fulgent Genetics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of any positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The number of shares sold is relatively small compared to the total shares owned by the CFO, suggesting this is a routine tax-related transaction rather than a significant change in the executive's investment position.
• Similar transactions are regularly reported by executives at other companies in the biotechnology and healthcare sectors, such as Exact Sciences (EXAS) and Illumina (ILMN).

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Fulgent Genetics, FLGT, Paul Kim, CFO, stock sale, tax obligations, restricted stock units, insider trading